{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T02:04:15Z","timestamp":1793930655322,"version":"4.8.0"},"reference-count":30,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005378","name":"Hacettepe \u00dcniversitesi","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005378","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.com.au","clinicalkey.es","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Seminars in Arthritis and Rheumatism"],"published-print":{"date-parts":[[2024,8]]},"DOI":"10.1016\/j.semarthrit.2024.152466","type":"journal-article","created":{"date-parts":[[2024,5,20]],"date-time":"2024-05-20T16:03:33Z","timestamp":1716221013000},"page":"152466","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["Assessing the quality of forced vital capacity measurement in patients with systemic sclerosis"],"prefix":"10.1016","volume":"67","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5010-9114","authenticated-orcid":false,"given":"G\u00fcll\u00fc Sandal","family":"Uzun","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alper","family":"Sar\u0131","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"O\u011fuz","family":"Karc\u0131o\u011flu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elif Naz","family":"Sancar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erdin\u00e7","family":"Unald\u0131","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B\u00fc\u015fra","family":"F\u0131rlatan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G\u00f6zde Sevgi","family":"Bayram","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Levent","family":"K\u0131l\u0131\u00e7","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ali","family":"Akdo\u011fan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.semarthrit.2024.152466_bib0001","doi-asserted-by":"crossref","first-page":"1685","DOI":"10.1016\/S0140-6736(17)30933-9","article-title":"Systemic sclerosis","volume":"390","author":"Denton","year":"2017","journal-title":"Lancet Lond Engl"},{"key":"10.1016\/j.semarthrit.2024.152466_bib0002","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1016\/S2213-2600(19)30480-1","article-title":"Systemic sclerosis-associated interstitial lung disease","volume":"8","author":"Perelas","year":"2020","journal-title":"Lancet Respir Med"},{"key":"10.1016\/j.semarthrit.2024.152466_bib0003","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1016\/S2213-2600(16)30152-7","article-title":"Mycophenolate mofetil versus oral cyclophosphamide in scleroderma-related interstitial lung disease (SLS II): a randomised controlled, double-blind, parallel group trial","volume":"4","author":"Tashkin","year":"2016","journal-title":"Lancet Respir Med"},{"key":"10.1016\/j.semarthrit.2024.152466_bib0004","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1016\/S2213-2600(20)30318-0","article-title":"Tocilizumab in systemic sclerosis: a randomised, double-blind, placebo-controlled, phase 3 trial","volume":"8","author":"Khanna","year":"2020","journal-title":"Lancet Respir Med"},{"key":"10.1016\/j.semarthrit.2024.152466_bib0005","doi-asserted-by":"crossref","first-page":"2518","DOI":"10.1056\/NEJMoa1903076","article-title":"Nintedanib for systemic sclerosis-associated interstitial lung disease","volume":"380","author":"Distler","year":"2019","journal-title":"N Engl J Med"},{"key":"10.1016\/j.semarthrit.2024.152466_bib0006","doi-asserted-by":"crossref","first-page":"2655","DOI":"10.1056\/NEJMoa055120","article-title":"Cyclophosphamide versus placebo in scleroderma lung disease","volume":"354","author":"Tashkin","year":"2006","journal-title":"N Engl J Med"},{"key":"10.1016\/j.semarthrit.2024.152466_bib0007","doi-asserted-by":"crossref","first-page":"e70","DOI":"10.1164\/rccm.201908-1590ST","article-title":"Standardization of spirometry 2019 update. An official american thoracic society and european respiratory society technical statement","volume":"200","author":"Graham","year":"2019","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.semarthrit.2024.152466_bib0008","first-page":"912","article-title":"ATS\/ERS recommendations for standardized procedures for the online and offline measurement of exhaled lower respiratory nitric oxide and nasal nitric oxide","volume":"171","year":"2005","journal-title":"Am J Respir Crit Care Med 2005"},{"key":"10.1016\/j.semarthrit.2024.152466_bib0009","doi-asserted-by":"crossref","first-page":"1747","DOI":"10.1136\/annrheumdis-2013-204424","article-title":"2013 classification criteria for systemic sclerosis: an American college of rheumatology\/European league against rheumatism collaborative initiative","volume":"72","author":"van den Hoogen","year":"2013","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.semarthrit.2024.152466_bib0010","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1002\/art.1780220205","article-title":"Skin thickness and collagen content in progressive systemic sclerosis and localized scleroderma","volume":"22","author":"Rodnan","year":"1979","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.semarthrit.2024.152466_bib0011","first-page":"202","article-title":"Scleroderma (systemic sclerosis): classification, subsets and pathogenesis","volume":"15","author":"LeRoy","year":"1988","journal-title":"J Rheumatol"},{"key":"10.1016\/j.semarthrit.2024.152466_bib0012","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1056\/NEJM197502132920706","article-title":"Polymyositis and dermatomyositis (first of two parts)","volume":"292","author":"Bohan","year":"1975","journal-title":"N Engl J Med"},{"key":"10.1016\/j.semarthrit.2024.152466_bib0013","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1093\/eurheartj\/ehv317","volume":"37","author":"Gali\u00e8","year":"2016","journal-title":"Eur Heart J"},{"key":"10.1016\/j.semarthrit.2024.152466_bib0014","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.3390\/ijms17071189","article-title":"Orofacial manifestations and temporomandibular disorders of systemic scleroderma: an observational study","volume":"17","author":"Crincoli","year":"2016","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.semarthrit.2024.152466_bib0015","doi-asserted-by":"crossref","first-page":"e31780","DOI":"10.1097\/MD.0000000000031780","article-title":"Gastrointestinal involvement in systemic sclerosis: an updated review","volume":"101","author":"Nassar","year":"2022","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.semarthrit.2024.152466_bib0016","first-page":"e547","article-title":"Clinical manifestations and diagnosis of axial spondyloarthritis","volume":"27","author":"Walsh","year":"2021","journal-title":"J Clin Rheumatol Pract Rep Rheum Musculoskelet Dis"},{"key":"10.1016\/j.semarthrit.2024.152466_bib0017","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1136\/annrheumdis-2017-211400","volume":"76","author":"Aggarwal","year":"2017","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.semarthrit.2024.152466_bib0018","doi-asserted-by":"crossref","first-page":"1747","DOI":"10.1093\/rheumatology\/kes160","article-title":"Malnutrition in systemic sclerosis","volume":"51","author":"Harrison","year":"2012","journal-title":"Rheumatol Oxf Engl"},{"key":"10.1016\/j.semarthrit.2024.152466_bib0019","first-page":"250","article-title":"Evaluation of vitamin B12 deficiency and associated factors in patients with systemic sclerosis","volume":"24","author":"Tas Kilic","year":"2018","journal-title":"J Clin Rheumatol Pract Rep Rheum Musculoskelet Dis"},{"key":"10.1016\/j.semarthrit.2024.152466_bib0020","doi-asserted-by":"crossref","DOI":"10.1136\/bmjquality.u201374.w1122","article-title":"The utilisation of the MUST nutritional screening tool on vascular surgical wards","volume":"2","author":"Tewari","year":"2013","journal-title":"BMJ Qual Improv Rep"},{"key":"10.1016\/j.semarthrit.2024.152466_bib0021","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0181692","article-title":"Predictors of lung function test severity and outcome in systemic sclerosis-associated interstitial lung disease","volume":"12","author":"Le Gouellec","year":"2017","journal-title":"PLoS ONE"},{"key":"10.1016\/j.semarthrit.2024.152466_bib0022","doi-asserted-by":"crossref","first-page":"1471","DOI":"10.1183\/13993003.00347-2016","article-title":"Exercise, ageing and the lung","volume":"48","author":"Roman","year":"2016","journal-title":"Eur Respir J"},{"key":"10.1016\/j.semarthrit.2024.152466_bib0023","doi-asserted-by":"crossref","first-page":"2422","DOI":"10.1080\/09638288.2022.2096126","article-title":"Respiratory dysfunction in patients with chronic neck pain: systematic review and meta-analysis","volume":"45","author":"L\u00f3pez-de-Uralde-Villanueva","year":"2023","journal-title":"Disabil Rehabil"},{"key":"10.1016\/j.semarthrit.2024.152466_bib0024","doi-asserted-by":"crossref","DOI":"10.1016\/j.resp.2023.104167","article-title":"Ventilatory limitations in patients with HFpEF and obesity","volume":"318","author":"Babb","year":"2023","journal-title":"Respir Physiol Neurobiol"},{"key":"10.1016\/j.semarthrit.2024.152466_bib0025","article-title":"Pulmonary function tests as outcomes for systemic sclerosis interstitial lung disease","volume":"27","author":"Caron","year":"2018","journal-title":"Eur Respir Rev Off J Eur Respir Soc"},{"key":"10.1016\/j.semarthrit.2024.152466_bib0026","doi-asserted-by":"crossref","first-page":"1286","DOI":"10.1513\/AnnalsATS.201802-079OC","article-title":"Longitudinal changes in quantitative interstitial lung disease on computed tomography after immunosuppression in the scleroderma lung study II","volume":"15","author":"Goldin","year":"2018","journal-title":"Ann Am Thorac Soc"},{"key":"10.1016\/j.semarthrit.2024.152466_bib0027","doi-asserted-by":"crossref","first-page":"e18","DOI":"10.1164\/rccm.202202-0399ST","article-title":"Idiopathic pulmonary fibrosis (an update) and progressive pulmonary fibrosis in adults: an official ATS\/ERS\/JRS\/ALAT clinical practice guideline","volume":"205","author":"Raghu","year":"2022","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.semarthrit.2024.152466_bib0028","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1183\/09031936.00155108","article-title":"Marginal decline in forced vital capacity is associated with a poor outcome in idiopathic pulmonary fibrosis","volume":"35","author":"Zappala","year":"2010","journal-title":"Eur Respir J"},{"key":"10.1016\/j.semarthrit.2024.152466_bib0029","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1164\/rccm.201709-1845OC","article-title":"Reliability and minimal clinically important differences of forced vital capacity: results from the Scleroderma Lung Studies (SLS-I and SLS-II)","volume":"197","author":"Kafaja","year":"2018","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.semarthrit.2024.152466_bib0030","doi-asserted-by":"crossref","first-page":"00210","DOI":"10.1183\/23120541.00210-2023","article-title":"Weak to no correlation between quantitative high-resolution computed tomography metrics and lung function change in fibrotic diseases","volume":"9","author":"Zou","year":"2023","journal-title":"ERJ Open Res"}],"container-title":["Seminars in Arthritis and Rheumatism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0049017224001069?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0049017224001069?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,7,4]],"date-time":"2024-07-04T02:47:09Z","timestamp":1720061229000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0049017224001069"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8]]},"references-count":30,"alternative-id":["S0049017224001069"],"URL":"https:\/\/doi.org\/10.1016\/j.semarthrit.2024.152466","relation":{},"ISSN":["0049-0172"],"issn-type":[{"value":"0049-0172","type":"print"}],"subject":[],"published":{"date-parts":[[2024,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Assessing the quality of forced vital capacity measurement in patients with systemic sclerosis","name":"articletitle","label":"Article Title"},{"value":"Seminars in Arthritis and Rheumatism","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.semarthrit.2024.152466","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"152466"}}